# CATALYST PHARMACEUTICALS, INC. (CPRX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from CATALYST PHARMACEUTICALS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CPRX/mda/fy2025/): filed 2026-02-25; accession 0001193125-26-071525 (https://www.sec.gov/Archives/edgar/data/1369568/000119312526071525/cprx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CPRX/mda/fy2024/): filed 2025-02-26; accession 0000950170-25-027714 (https://www.sec.gov/Archives/edgar/data/1369568/000095017025027714/cprx-20241231.htm)
- [FY 2023 MD&A](/company/CPRX/mda/fy2023/): filed 2024-02-28; accession 0001193125-24-050908 (https://www.sec.gov/Archives/edgar/data/1369568/000119312524050908/d723690d10k.htm)
- [FY 2022 MD&A](/company/CPRX/mda/fy2022/): filed 2023-03-15; accession 0001193125-23-071299 (https://www.sec.gov/Archives/edgar/data/1369568/000119312523071299/d421867d10k.htm)
- [FY 2021 MD&A](/company/CPRX/mda/fy2021/): filed 2022-03-16; accession 0001193125-22-077228 (https://www.sec.gov/Archives/edgar/data/1369568/000119312522077228/d159262d10k.htm)

Back to /company/CPRX/